| ECAT | YYY | ECAT / YYY | |
| Gain YTD | 12.057 | 4.858 | 248% |
| Net Assets | 1.57B | 707M | 222% |
| Total Expense Ratio | 1.30 | 3.23 | 40% |
| Turnover | 226.00 | 48.00 | 471% |
| Yield | 1.37 | 12.49 | 11% |
| Fund Existence | 5 years | 14 years | - |
| ECAT | YYY | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 72% | N/A |
| Stochastic ODDS (%) | 2 days ago 81% | 2 days ago 59% |
| Momentum ODDS (%) | 2 days ago 82% | 2 days ago 77% |
| MACD ODDS (%) | 2 days ago 70% | 2 days ago 82% |
| TrendWeek ODDS (%) | 2 days ago 85% | 2 days ago 75% |
| TrendMonth ODDS (%) | 2 days ago 86% | 2 days ago 71% |
| Advances ODDS (%) | 9 days ago 83% | 8 days ago 76% |
| Declines ODDS (%) | 16 days ago 79% | 16 days ago 76% |
| BollingerBands ODDS (%) | 2 days ago 71% | 6 days ago 71% |
| Aroon ODDS (%) | 2 days ago 89% | 2 days ago 70% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| JFNAX | 80.74 | 1.47 | +1.85% |
| Janus Henderson Global Life Sciences A | |||
| ACIOX | 13.88 | N/A | N/A |
| American Century International Opps I | |||
| VECRX | 23.68 | N/A | N/A |
| Virtus KAR Equity Income R6 | |||
| TAAHX | 37.53 | N/A | N/A |
| Transamerica Multi-Managed Balanced R | |||
| GFAFX | 86.54 | -0.46 | -0.53% |
| American Funds Growth Fund of Amer F1 | |||
A.I.dvisor indicates that over the last year, ECAT has been loosely correlated with BSX. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if ECAT jumps, then BSX could also see price increases.
| Ticker / NAME | Correlation To ECAT | 1D Price Change % | ||
|---|---|---|---|---|
| ECAT | 100% | N/A | ||
| BSX - ECAT | 64% Loosely correlated | -2.12% | ||
| CRM - ECAT | 62% Loosely correlated | -1.09% | ||
| AMT - ECAT | 56% Loosely correlated | +0.22% | ||
| NEE - ECAT | 55% Loosely correlated | -0.77% | ||
| MSFT - ECAT | 12% Poorly correlated | -3.18% | ||
More | ||||